Inhibition of Japanese encephalitis virus (JEV) replication by specific RNA aptamer against JEV methyltransferase

Biochem Biophys Res Commun. 2017 Jan 29;483(1):687-693. doi: 10.1016/j.bbrc.2016.12.081. Epub 2016 Dec 13.

Abstract

Japanese encephalitis virus (JEV) is the most common etiological agent of epidemic viral encephalitis. JEV encodes a single methyltransferase (MTase) domain located at the N-terminal region of the viral nonstructural protein NS5. JEV MTase is essential for viral replication and specifically catalyzes methylation of the viral RNA cap, which occurs exclusively in the cytoplasm. Therefore, JEV MTase is a potential target for antiviral therapy. Here, we identified specific and avid RNA aptamer (Kd ∼ 12 nM) with modified 2'-O-methyl pyrimidines against JEV MTase. The RNA aptamer efficiently inhibited viral cap methylation activity of MTase and interfered with JEV production in cells. Moreover, we generated a 24-mer truncated aptamer that could specifically bind to JEV MTase with high affinity (Kd ∼16 nM). The 24-mer aptamer efficiently inhibited JEV production and replication in cells. Therefore, MTase-specific RNA aptamer might be useful as an anti-JEV agent.

Keywords: Anti-viral agent; Japanese encephalitis virus; Methyltransferase; RNA aptamer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology*
  • Aptamers, Nucleotide / chemistry
  • Aptamers, Nucleotide / pharmacology*
  • Cell Line
  • Cricetinae
  • Encephalitis Virus, Japanese / chemistry
  • Encephalitis Virus, Japanese / drug effects
  • Encephalitis Virus, Japanese / genetics
  • Encephalitis Virus, Japanese / physiology
  • Methylation / drug effects
  • Methyltransferases / antagonists & inhibitors*
  • Methyltransferases / genetics
  • Nucleic Acid Conformation
  • RNA Caps / genetics
  • RNA Caps / metabolism*
  • RNA, Viral / genetics
  • RNA, Viral / metabolism*
  • SELEX Aptamer Technique
  • Transfection
  • Viral Nonstructural Proteins / antagonists & inhibitors*
  • Viral Nonstructural Proteins / genetics
  • Virus Replication / drug effects*

Substances

  • Antiviral Agents
  • Aptamers, Nucleotide
  • NS5 protein, flavivirus
  • RNA Caps
  • RNA, Viral
  • Viral Nonstructural Proteins
  • Methyltransferases